New somatostatin analogues for radiotherapy of somatostatin receptor expressing tumours

Italian Journal of Gastroenterology and Hepatology

Volumn 31, Issue 7 SUPPL. 2, 1999, Pages

  Stolz, B ^a   Smith Jones, P ^a   Albert, R ^a   Weckbecker, G ^a   Bruns, C ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Endocrine tumours; Somatostatin analogue; Somatostatin receptor

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE N,N,N,N,TETRAACETIC ACID OCTREOTIDE[DEXTRO PHENYLALANINE 1 TYROSINE 3]; ANTINEOPLASTIC AGENT; MITOMYCIN C; OCTREOTIDE; RECEPTOR SUBTYPE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG; YTTRIUM 90;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER RADIOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG SMALL CELL CANCER; MOUSE; NONHUMAN; PANCREAS TUMOR; PLASMA CLEARANCE; RAT; TUMOR VOLUME;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; NEUROENDOCRINE TUMORS; OCTREOTIDE; RATS; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 0032703410     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Reubi JC, Krenning E, Lamberts SWJ, Kvols L. In vitro detection of somatostatin receptors in human tumors. Metabolism 1992;41:104-10.
2. 3-octreotide: the Rotterdam experience with more than 1,000 patients. Eur J Nucl Med 1993;20:283-92.
3. Bruns C, Stolz B, Albert R, Marbach P, Pless J. OctreoScan111 for imaging of a SRIF receptor-positive islet cell tumor in rat. In: Steiffer EF, Reaven GM, editors. Somatostatin receptor-imaging. Hormon Metab Res Suppl 1993;27:5-11.
4. Stolz B, Smith-Jones P, Albert R, Tolcsvai L, Briner U, Ruser G, et al. Somatostatin analogues for somatostatin-receptor mediated radiotherapy of cancer. Digestion 1996;57(Suppl. 1):17-21.
5. Smith-Jones P, Stolz B, Albert R, Knecht H, Bruns C. Synthesis, biodistribution and renal handling of various chelate-somatostatin conjugates with metabolizable linking groups. Nucl Med Biol 1997;24:761-9.
6. 3]-Octreotide (SMT487): Two chelators for systemic delivery of radiotherapeutical nuclides to somatostatin receptor positive tumors in man. Bioorg Med Chem Lett 1998;8:1207-10.
7. De Nardo GL, Kroger LA, De Nardo SJ, Miers LA, Salako Q, Kukis DL, et al. Comparative toxicity studies of Yttrium-90 Mx-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3). Cancer 1994;73(Suppl.):1012-22.
8. Bruns C, Weckbocker C, Raulf F, Lübbert H, Hoyer D. Characterization of somatostatin receptor subtypes. Ciba Found Symp 1995;190:89-101.
9. 90Y] SMT487) eradicates experimental rat pancreatic CA 20948 tumours. Eur J Nucl Med 1998;25:668-74.